History
Pyrus was formed by Drs Carol O'Connor and Jill Ogden to meet the market demand for synergistic commercial and drug development expertise.
This synergy enables our clients to gain access to an optimum blend of skills, experience and vision. Pyrus offers a cost-effective, professional, flexible and reliable service to ensure the efficient transition of our clients’ products from the initial concept into drug development and beyond.